Signature Framework
RESPIRA™ — A Structured Framework for Building Respiratory Businesses
Seven sequential stages that turn a respiratory ambition into a portfolio, a supply chain and a commercial engine.
Signature Framework
Introducing RESPIRA™
A structured framework for building respiratory businesses.
R
RESEARCH
Stage Detail
What Happens at Each Stage
R
RESEARCH
Market, disease, competition and opportunity mapping
E
EVALUATE
Molecules, salts, dosage forms and commercial economics
S
SELECT
Portfolio prioritization
P
PARTNER
Manufacturing, device and technology partners
I
INSTITUTIONALIZE
Hospital, KOL, procurement and tender strategy
R
ROUTE-TO-MARKET
Sales force, distribution, pricing and launch strategy
A
ACCELERATE
Scale winning products and expand the franchise
Flagship Program
Respiratory Business Launch Blueprint™
A practical roadmap for entrepreneurs ready to build a respiratory business.
01
MARKET
Opportunity Assessment
02
PORTFOLIO
Product Selection
03
DEVICE
DPI / MDI / Nebulization Strategy
04
MANUFACTURING
Partner Evaluation
05
COMMERCIAL
Pricing + Positioning + Institutional Strategy
06
LAUNCH
90-Day Execution Roadmap
Strategic Tool
Respiratory Portfolio Scoring Model
Score a respiratory opportunity across eight commercial criteria to see how it holds up before capital is committed.
Portfolio Score
24/40
Viable with focused refinement
Portfolio recommendations are strategic screening tools and must be validated against current market data, regulatory requirements, pricing controls, intellectual property and manufacturer capabilities before investment.
Consultation
Start With a Respiratory Portfolio Audit
A focused diagnostic session for entrepreneurs and pharma business owners who want to evaluate a respiratory opportunity before committing significant capital.
- Market opportunity review
- Current portfolio review
- Investment-range discussion
- Product strategy
- Device strategy
- Manufacturing considerations
- Institutional potential
- Priority action plan